Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis

Oncogene

Volumn 24, Issue 3, 2005, Pages 445-456

  Kishimoto, Koji ^a,b   Liu, Shumei ^a   Tsuji, Takanori ^a   Olson, Karen A ^a,c   Hu, Guo Fu ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c Archemix Corporation   (United States)

Author keywords

Angiogenesis; Angiogenic factors; Angiogenin; Nuclear translocation; Ribosome biogenesis; RRNA transcription

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; RIBOSOME RNA; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HELA CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RIBOSOME; RNA TRANSCRIPTION;

ANGIOGENESIS INDUCING AGENTS; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UMBILICAL VEINS;

ANIMALIA;

EID: 13244264730     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208223     Document Type: Article

References (45)

1. Adams SA and Subramanian V. (1999). Angiogenesis, 3, 189-199.
2. Au S, Weiner N and Schacht J. (1986). Antimicrob. Agents Chemother., 30, 395-397.
3. Barton DP, Cai A, Wendt K, Young M, Gamero A and De Cesare S. (1997). Clin. Cancer Res., 3, 1579-1586.
4. Bergers G and Benjamin LE. (2003). Nat. Rev. Cancer, 3, 401-410.
5. Bicknell R and Vallee BL. (1988). Proc. Natl. Acad. Sci. USA, 85, 5961-5965.
6. Bodner-Adler B, Hefler L, Bodner K, Leodolter S, Frischmuth K, Kainz C and Mayerhofer K. (2001). Anticancer Res., 21, 809-812.
7. Eberle K, Oberpichler A, Trantakis C, Krupp W, Knupfer M, Tschesche H and Seifert V. (2000). Anticancer Res., 20, 1679-1684.
8. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF and Vallee BL. (1985). Biochemistry, 24, 5480-5486.
9. Folkman J. (2002). Cancer Cell, 1, 113-115.
10. Folkman J. (2003). Curr. Mol. Med., 3, 643-651.
11. Fu X, Roberts WG, Nobile V, Shapiro R and Kamps MP. (1999). Growth Factors, 17, 125-137.
12. Hanahan D and Folkman J. (1996). Cell, 86, 353-364.
13. Homer JJ, Greenman J and Stafford ND. (2002). Clin. Otolaryngol., 27, 32-37.
14. Hu G-F. (1998). Proc. Natl. Acad. Sci. USA, 95, 9791-9795.
15. Hu G-F, Chang SI, Riordan JF and Vallee BL. (1991). Proc. Natl. Acad. Sci. USA, 88, 2227-2231.
16. Hu G-F and Riordan JF. (1993). Biochem. Biophys. Res. Commun., 197, 682-687.
17. Hu G-F, Riordan JF and Vallee BL. (1994). Proc. Natl. Acad. Sci. USA, 91, 12096-12100.
18. Hu G-F, Riordan JF and Vallee BL. (1997). Proc. Natl. Acad. Sci. USA, 94, 2204-2209.
19. Hu G-F, Strydom DJ, Fett JW, Riordan JF and Vallee BL. (1993). Proc. Natl. Acad. Sci. USA, 90, 1217-1221.
20. Hu G-F, Xu C and Riordan JF. (2000). J. Cell. Biochem., 76, 452-462.
21. Imaizumi T, Itaya H, Nasu S, Yoshida H, Matsubara Y, Fujimoto K, Matsumiya T, Kimura H and Satoh K. (2000). Thromb. Haemost., 83, 949-955.
22. Kinoshita M and Shimokado K. (1999). Arterioscler. Thromb. Vasc. Biol., 19, 2323-2329.
23. Kushlinskii NE, Babkina IV, Solov́ev YN and Trapeznikov NN. (2000). Bull. Exp. Biol. Med., 130, 691-693.
24. Li D, Bell J, Brown A and Berry CL. (1994). J. Pathol., 172, 171-175.
25. Liu S, Yu D, Xu ZP, Riordan JF and Hu G-F. (2001). Biochem. Biophys. Res. Commun., 287, 305-310.
26. Moenner M, Gusse M, Hatzi E and Badet J. (1994). Eur. J. Biochem., 226, 483-490.
27. Montero S, Guzman C, Cortes-Funes H and Colomer R. (1998). Clin. Cancer Res., 4, 2161-2168.
28. Moroianu J and Riordan JF. (1994). Proc. Natl. Acad. Sci. USA, 91, 1677-1681.
29. Olson KA, Byers HR, Key ME and Fett JW. (2001). Clin. Cancer Res., 7, 3598-3605.
30. Olson KA, Byers HR, Key ME and Fett JW. (2002). Int. J. Cancer, 98, 923-929.
31. Olson KA, Fett JW, French TC, Key ME and Vallee BL. (1995). Proc. Natl. Acad. Sci. USA, 92, 442-446.
32. Papetti M and Herman IM. (2002). Am. J. Physiol. Cell Physiol., 282, C947-C970.
33. Polakowski IJ, Lewis MK, Muthukkaruppan VR, Erdman B, Kubai L and Auerbach R. (1993). Am. J. Pathol., 143, 507-517.
34. Ribatti D, Vacca A and Presta M. (2002). Gen. Pharmacol., 35, 227-231.
35. Risau W. (1996). Cancer Met. Rev., 15, 149-151.
36. Ruggero D and Pandolfi PP. (2003). Nat. Rev. Cancer, 3, 179-192.
37. Ruschoff J, Plate K, Bittinger A and Thomas C. (1989). Pathol. Res. Pract., 185, 878-885.
38. Shimoyama S, Gansauge F, Gansauge S, Oohara T, Kaminishi M and Beger HG. (1999). Pancreas, 18, 225-230.
39. Shimoyama S, Shimizu N, Tsuji E, Yamasaki K, Kawahara M and Kaminishi M. (2002). Anticancer Res., 22, 1045-1052.
40. Trere D, Pession A and Derenzini M. (1989). Exp. Cell Res., 184, 131-137.
41. Ugurel S, Rappl G, Tilgen W and Reinhold U. (2001). J. Clin. Oncol., 19, 577-583.
42. Williams PD, Bennett DB, Gleason CR and Hottendorf GH. (1987). Antimicrob. Agents Chemother., 31, 570-574.
43. Wilting J, Christ B and Bokeloh M. (1991). Anat. Embryol., 183, 259-271.
44. Xu ZP, Tsuji T, Riordan JF and Hu G-F. (2002). Biochem. Biophys. Res. Commun., 294, 287-292.
45. Xu ZP, Tsuji T, Riordan JF and Hu G-F. (2003). Biochemistry, 42, 121-128.